Saakshi Medtech seeks waiver for Q4FY26 filing delay

1 min read     Updated on 10 Jun 2026, 06:49 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Saakshi Medtech and Panels Limited has requested the National Stock Exchange of India (NSE) to waive a ₹2,000 fine imposed for a one-day delay in submitting its shareholding pattern for the quarter ended March 31, 2026. The company attributed the delay to an unforeseen technical issue on the NEAPS portal and confirmed the filing was completed on May 22, 2026. The Board of Directors has been apprised of the incident and has directed the strengthening of internal compliance mechanisms.

powered bylight_fuzz_icon
42599981

*this image is generated using AI for illustrative purposes only.

Saakshi Medtech and Panels Limited has approached the National Stock Exchange of India (NSE) to waive a ₹2,000 penalty levied for a one-day delay in filing its shareholding pattern for the quarter ended March 31, 2026. The company attributed the delay to an unforeseen technical issue on the NEAPS portal, which disrupted the upload process despite preparatory steps being taken within the prescribed timelines. The disclosure was eventually submitted on May 22, 2026, prior to the issuance of the penalty notice on May 14, 2026.

The NSE issued the notice under Regulation 31 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, citing non-compliance with the standard operating procedure for filing shareholding patterns. The exchange identified a one-day delay in compliance, resulting in a base fine of ₹2,000 and an additional GST of ₹360, bringing the total payable amount to ₹2,360. The notice warned that failure to pay the fine or ensure compliance could lead to the freezing of promoter shareholdings and a shift in trading to the 'Trade for Trade' basis.

In its response, Saakshi Medtech & Panels stated that the delay was inadvertent and unintentional, occurring despite bona fide efforts to comply with regulatory requirements. The company emphasized that there was no deliberate or malafide intent behind the non-compliance. It further noted that the matter had been placed before its Board of Directors, who have taken cognizance of the delay and directed the strengthening of internal compliance monitoring and reporting mechanisms to prevent recurrence.

The company has formally requested the waiver of the fine, citing the bona fide nature of the delay arising from technical difficulties and the fact that compliance has since been achieved. It assured the exchange of its continued cooperation and commitment to maintaining high standards of regulatory compliance. Mrs. Mayuri Aniket Latkar, CFO and Whole-Time Director, signed the response submitted on June 9, 2026.

Details of Penalty

Regulation Quarter Fine amount per day (₹) Days of non-compliance Fine amount (₹)
REGULATION 31(1) 31-Mar-2026 2000 1 2000
Total Fine 2000
GST @18% 360
Total 2360

Historical Stock Returns for Saakshi Medtech & Panels

1 Day5 Days1 Month6 Months1 Year5 Years
+2.83%+1.95%-5.98%+33.87%+53.21%+65.00%

How will the NSE likely respond to the waiver request given the technical issue justification?

What specific internal compliance measures will the Board implement to prevent future portal-related delays?

Could this incident trigger a broader review of the NEAPS portal's reliability by the exchange?

Saakshi Medtech & Panels
View Company Insights
View All News
like17
dislike

Saakshi Medtech shareholders approve capital increase at EGM

1 min read     Updated on 05 Jun 2026, 09:31 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Saakshi Medtech and Panels Limited received shareholder approval to increase its authorized capital and issue equity shares on a preferential basis during an EGM held on June 2, 2026. The resolutions passed with 13,520,900 votes in favor, representing 76.58% of total outstanding shares, with no votes against. The voting results were scrutinized by Jay Pandya & Associates and submitted to the National Stock Exchange of India Limited on June 4, 2026.

powered bylight_fuzz_icon
42001450

*this image is generated using AI for illustrative purposes only.

Saakshi Medtech and Panels Limited secured shareholder approval to increase its authorized capital and issue equity shares on a preferential basis during an Extra-Ordinary General Meeting (EGM) held on June 2, 2026. The resolutions were passed with a requisite majority, with 13,520,900 votes polled representing 76.58% of the total outstanding shares. There were no votes cast against any of the resolutions. Mrs. Mayuri Aniket Latkar, Chief Financial Officer and Whole-time Director, submitted the voting results to the National Stock Exchange of India Limited on June 4, 2026, under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Voting Results

The remote e-voting process was scrutinized by Jay Pandya, Proprietor of M/s. Jay Pandya & Associates, Company Secretaries. The voting period remained open from May 29, 2026, to June 1, 2026. The promoter group, holding 13,210,100 shares, participated fully via e-voting, while public shareholders also cast their votes through the remote e-voting facility.

Resolutions Passed

Sr. No. Particulars of Resolution Nature of Resolution Votes in Favor Votes Against
1. Increase in Authorized Capital and consequential alteration in the Capital Clause of Memorandum of Association Ordinary Resolution 13,520,900 0
2. Approval of issue of Equity Shares on Preferential Basis for consideration other than cash Special Resolution 13,520,900 0

Meeting Details

The EGM commenced at 03:00 P.M. and concluded at 03:19 P.M. on June 2, 2026. The company confirmed that neither the promoters nor the promoter group were interested in the agenda or resolutions presented. The results of the remote e-voting were announced within the stipulated timeframe and intimated to the stock exchanges.

Historical Stock Returns for Saakshi Medtech & Panels

1 Day5 Days1 Month6 Months1 Year5 Years
+2.83%+1.95%-5.98%+33.87%+53.21%+65.00%

What specific strategic acquisitions or investments does Saakshi Medtech plan to fund through the preferential issue of equity shares?

How will the dilution of existing shareholding impact the company's earnings per share and stock valuation in the short term?

Who are the potential investors likely to participate in the preferential allotment, and what expertise or value will they bring?

Saakshi Medtech & Panels
View Company Insights
View All News
like16
dislike

More News on Saakshi Medtech & Panels

1 Year Returns:+53.21%